Experience
PENG Bixin, HUANG Chunli, CHEN Yingping, WU Xiuzhen, XU Chaoyan
[Abstract].Objective: To explore the clinical efficacy of Amlodipine Folic Acid Tablets in the treatment of H-type hypertension and pharmacoeconomics evaluation. Method: A total of 141 patients with H-type hypertension admitted to the First Hospital of Sanming Affiliated to Fujian Medical University from August 2022 to August 2023 were retrospectively selected as the study objects. According to the use of drugs, they were divided into group A, group B and group C, 47 cases in each group. Group A was given Amlodipine Besylate Tablets, group B was given Amlodipine Folic Acid Tablets, group C was given Enalapril Maleate Folic Acid Tablets. The clinical efficacy, blood pressure index, homocysteine (Hcy), vascular endothelial function and inflammatory factors before and after treatment, adverse reactions and pharmacoeconomics were compared between the two groups. Result: The total effective rate of group B was significantly higher than that of group A and group C, and the difference was statistically significant (P<0.05). After treatment, systolic blood pressure (SBP), diastolic blood pressure (DBP) and Hcy levels were all reduced in the three groups, and SBP, DBP and Hcy levels in group B were lower than those in group A and group C, the indexes in the group C were lower than those in the group A, the differences were statistically significant (P<0.05). After treatment, nitric oxide (NO) in the three groups were increased, endothelin-1 (ET-1), tumor necrosis factor-α (TNF-α), interleukin-6 (interleukin-6), and hypersensitive C-reactive protein (hs-CRP) were decreased, and the level of NO in group B was significantly higher than that in group A and group C, while the levels of ET-1, TNF-α, IL-6 and hs-CRP were significantly lower than those in group A and group C, the levels of NO in group C was significantly higher than that in group A, and the levels of ET-1, TNF-α, IL-6 and hs-CRP were significantly lower than those in group A, the differences were statistically significant (P<0.05). There was no significant difference in the incidence of adverse reactions among the three groups (P>0.05). The drug cost of group B was lower than that of group A and group C, group C was lower than group A, and the differences were statistically significant (P<0.05). Conclusion: Amlodipine Folic Acid Tablets has good clinical effect in the treatment of H-type hypertension, which not only effectively reduces blood pressure, Hcy level and inflammatory factor level, but also improves vascular endothelial function, which is more economical.